Related references
Note: Only part of the references are listed.A PGC-1α Isoform Induced by Resistance Training Regulates Skeletal Muscle Hypertrophy
Jorge L. Ruas et al.
CELL (2012)
Elevated PGC-1α Activity Sustains Mitochondrial Biogenesis and Muscle Function without Extending Survival in a Mouse Model of Inherited ALS
Sandrine Da Cruz et al.
CELL METABOLISM (2012)
A greatly extended PPARGC1A genomic locus encodes several new brain-specific isoforms and influences Huntington disease age of onset
Selma M. Soyal et al.
HUMAN MOLECULAR GENETICS (2012)
NT-PGC-1α Protein Is Sufficient to Link β3-Adrenergic Receptor Activation to Transcriptional and Physiological Components of Adaptive Thermogenesis
Ji Suk Chang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Research Resource: A Genome-Wide Study Identifies Potential New Target Genes for POU1F1
Jean-Paul Herman et al.
MOLECULAR ENDOCRINOLOGY (2012)
EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans
Annelies Van Hoecke et al.
NATURE MEDICINE (2012)
PGC-1α Rescues Huntington's Disease Proteotoxicity by Preventing Oxidative Stress and Promoting TFEB Function
Taiji Tsunemi et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Characterization of Novel Peroxisome Proliferator-activated Receptor γ Coactivator-1α (PGC-1α) Isoform in Human Liver
Thomas K. Felder et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Amyotrophic lateral sclerosis
Matthew C. Kiernan et al.
LANCET (2011)
A mutation in the dynein heavy chain gene compensates for energy deficit of mutant SOD1 mice and increases potentially neuroprotective IGF-1
Anissa Fergani et al.
MOLECULAR NEURODEGENERATION (2011)
Peroxisome proliferator activator receptor gamma coactivator-1alpha (PGC-1α) improves motor performance and survival in a mouse model of amyotrophic lateral sclerosis
Wei Zhao et al.
MOLECULAR NEURODEGENERATION (2011)
PGC-1α PROTECTS NEURONS AND ALTERS DISEASE PROGRESSION IN AN AMYOTROPHIC LATERAL SCLEROSIS MOUSE MODEL
Huiyun Liang et al.
MUSCLE & NERVE (2011)
Engrailed protects mouse midbrain dopaminergic neurons against mitochondrial complex I insults
Daniel Alvarez-Fischer et al.
NATURE NEUROSCIENCE (2011)
Clinical genetics of amyotrophic lateral sclerosis: what do we really know?
Peter M. Andersen et al.
NATURE REVIEWS NEUROLOGY (2011)
The Role of PGC-1 alpha in the Pathogenesis of Neurodegenerative Disorders
Krisztina Rona-Voeroes et al.
CURRENT DRUG TARGETS (2010)
Incidence of amyotrophic lateral sclerosis in Europe
Giancarlo Logroscino et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)
Mice with a mutation in the dynein heavy chain 1 gene display sensory neuropathy but lack motor neuron disease
Luc Dupuis et al.
EXPERIMENTAL NEUROLOGY (2009)
Alternative mRNA Splicing Produces a Novel Biologically Active Short Isoform of PGC-1α
Yubin Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1α
Zoltan Arany et al.
NATURE (2008)
Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory
Ying Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators
Julie St-Pierre et al.
CELL (2006)
Possible gender-dependent association of vascular endothelial growth factor (VEGF) gene and ALS
R. Fernandez-Santiago et al.
NEUROLOGY (2006)
Onset and progression in inherited ALS determined by motor neurons and microglia
Severine Boillee et al.
SCIENCE (2006)
PGC-1 coactivators: inducible regulators of energy metabolism in health and disease
BN Finck et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Background and gender effects on survival in the TgN(SOD1-G93A) 1 Gur mouse model of ALS
TD Heiman-Patterson et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)
PGC-1α deficiency causes multi-system energy metabolic derangements:: Muscle dysfunction, abnormal weight control and hepatic steatosis
TC Leone et al.
PLOS BIOLOGY (2005)
Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS
E Storkebaum et al.
NATURE NEUROSCIENCE (2005)
Androgen receptor YAC Transgenic mice recapitulate SBMA motor neuronopathy and implicate VEGF164 in the motor neuron degeneration
BL Sopher et al.
NEURON (2004)
Evidence for defective energy homeostasis in amyotrophic lateral sclerosis:: benefit of a high-energy diet in a transgenic mouse
L Dupuis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Inflammatory mediators and growth factors in the spinal cord of G93A SODI rats
YH Xie et al.
NEUROREPORT (2004)
VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model
M Azzouz et al.
NATURE (2004)
Defects in adaptive energy metabolism with CNS-Linked hyperactivity in PGC-1α null mice
JD Lin et al.
CELL (2004)
VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death
D Lambrechts et al.
NATURE GENETICS (2003)
Identification of patterns in biological sequences at the ALGGEN server:: PROMO and MALGEN
D Farré et al.
NUCLEIC ACIDS RESEARCH (2003)
El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis
BR Brooks et al.
AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS (2000)
Modulation of estrogen receptor-α transcriptional activity by the coactivator PGC-1
I Tcherepanova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
